Tamoxifen Citrate
- Product NDC
- 51862-446
- 11-digit product format
- 518620446
- Labeler code
- 51862
- Product ID
- 51862-446_729b8661-687d-4cc9-b0fd-6bdd09282abb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tamoxifen Citrate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Mayne Pharma Inc.
- Application
- ANDA075797
- Marketing category
- ANDA
- Marketing start
- 2016-08-03
- Marketing end
- 0000-00-00
- Substance
- TAMOXIFEN CITRATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51862-446-01 | 51862044601 | 100 TABLET, FILM COATED in 1 BOTTLE (51862-446-01) | 2016-08-03 | 0000-00-00 | No | No | Current |
| 51862-446-05 | 51862044605 | 500 TABLET, FILM COATED in 1 BOTTLE (51862-446-05) | 2016-08-03 | 0000-00-00 | No | No | Current |
| 51862-446-10 | 51862044610 | 1000 TABLET, FILM COATED in 1 BOTTLE (51862-446-10) | 2016-08-03 | 0000-00-00 | No | No | Current |
| 51862-446-30 | 51862044630 | 30 TABLET, FILM COATED in 1 BOTTLE (51862-446-30) | 2016-08-03 | 0000-00-00 | No | No | Current |